Stocks Comparison
Caris Life Sciences vs Labcorp: revenue, profit, margins and growth compared
Caris Life Sciences brought in $812M of revenue in fiscal 2025, Labcorp $14B in fiscal 2025. Revenue changed by +97.0% at Caris Life Sciences and +7.2% at Labcorp on the year before, so Caris Life Sciences grew faster. Caris Life Sciences kept -8.4% of its revenue as net profit, Labcorp 6.3%. Free cash flow was $66.9M at Caris Life Sciences and $1.2B at Labcorp.
Side by side, latest fiscal year
| CAI | LH | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $812M | $14B |
| Revenue growth | +97.0% | +7.2% |
| Net income | -$68.1M | $876.5M |
| Net margin | -8.4% | 6.3% |
| Free cash flow | $66.9M | $1.2B |
| Free cash flow margin | 8.2% | 8.6% |
| Earnings per share (diluted) | -$3.22 | $10.46 |
| Cash | $796.3M | $532.3M |
| Debt | $378.5M | $5.6B |
| Price to earnings | n/a | 29.6 |
| Market value | $9B | $25.1B |
| Dividend yield | n/a | 0.93% |
| Rank by revenue in sector | #161 of 523 · Health care | #35 of 523 · Health care |
Over the years
Questions about Caris Life Sciences and Labcorp
Which is bigger by revenue, Caris Life Sciences or Labcorp?
Labcorp is bigger by revenue: $14B in fiscal 2025, against $812M for Caris Life Sciences in fiscal 2025.
Which keeps more of its revenue as profit, Caris Life Sciences or Labcorp?
Caris Life Sciences had a net margin of -8.4% in fiscal 2025; Labcorp had 6.3% in fiscal 2025.
Which grew revenue faster, Caris Life Sciences or Labcorp?
In their latest fiscal years revenue changed by +97.0% at Caris Life Sciences and +7.2% at Labcorp.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.